Market Research Logo

El Salvador Pharmaceuticals & Healthcare Q4 2018

El Salvador Pharmaceuticals & Healthcare Q4 2018

Key View:

A combination of shifting US policy, increasingly fractured domestic politics and low per capita spending onmedicines makes El Salvador one of the regions riskier proposition for pharmaceutical investment. Despite this, a steady number ofcollaborations with international organisations and businesses is improving the standard of healthcare and raising the long-termgrowth prospects of the country's low penetration of pharmaceuticals and medical equipment.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
El Salvador Industry Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
Ancalmo Internacional
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report